These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 24760551)

  • 21. Characterization of ionic currents in human mesenchymal stem cells from bone marrow.
    Li GR; Sun H; Deng X; Lau CP
    Stem Cells; 2005 Mar; 23(3):371-82. PubMed ID: 15749932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Seventh Annual Ion Channel Retreat Vancouver, Canada, June 29-July 1, 2009.
    Brugger S; Kennedy S; King N
    Assay Drug Dev Technol; 2010 Feb; 8(1):19-26. PubMed ID: 20158438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activators of cation channels: potential in treatment of channelopathies.
    Seebohm G
    Mol Pharmacol; 2005 Mar; 67(3):585-8. PubMed ID: 15608141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interactions of the 5-hydroxytryptamine 3 antagonist class of antiemetic drugs with human cardiac ion channels.
    Kuryshev YA; Brown AM; Wang L; Benedict CR; Rampe D
    J Pharmacol Exp Ther; 2000 Nov; 295(2):614-20. PubMed ID: 11046096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 1-[1-Hexyl-6-(methyloxy)-1H-indazol-3-yl]-2-methyl-1-propanone, a potent and highly selective small molecule blocker of the large-conductance voltage-gated and calcium-dependent K+ channel.
    Zeng H; Gordon E; Lin Z; Lozinskaya IM; Willette RN; Xu X
    J Pharmacol Exp Ther; 2008 Oct; 327(1):168-77. PubMed ID: 18591221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studying cardiac arrhythmias in the mouse--a reasonable model for probing mechanisms?
    Nerbonne JM
    Trends Cardiovasc Med; 2004 Apr; 14(3):83-93. PubMed ID: 15121155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of S5P alpha-helix charge mutants on inactivation of hERG K+ channels.
    Clarke CE; Hill AP; Zhao J; Kondo M; Subbiah RN; Campbell TJ; Vandenberg JI
    J Physiol; 2006 Jun; 573(Pt 2):291-304. PubMed ID: 16556651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High throughput functional screening of an ion channel library for drug safety and efficacy.
    Brown AM
    Eur Biophys J; 2009 Mar; 38(3):273-8. PubMed ID: 18677468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The D3-dopaminergic agonist 7-hydroxy-dipropylaminotetralin (7-OH-DPAT) increases cardiac action potential duration and blocks human ether-a-go-go-related gene K+ channel.
    Torres-Jácome J; Tejeda-Chávez HR; Rodríguez-Menchaca AA; Sánchez-Chapula JA; Navarro-Polanco RA
    J Cardiovasc Pharmacol; 2006 May; 47(5):656-62. PubMed ID: 16775504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electromechanical window negativity in genotyped long-QT syndrome patients: relation to arrhythmia risk.
    ter Bekke RM; Haugaa KH; van den Wijngaard A; Bos JM; Ackerman MJ; Edvardsen T; Volders PG
    Eur Heart J; 2015 Jan; 36(3):179-86. PubMed ID: 25205533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biology of cardiac arrhythmias: ion channel protein trafficking.
    Delisle BP; Anson BD; Rajamani S; January CT
    Circ Res; 2004 Jun; 94(11):1418-28. PubMed ID: 15192037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene expression profiling of human cardiac potassium and sodium channels.
    Ordög B; Brutyó E; Puskás LG; Papp JG; Varró A; Szabad J; Boldogkoi Z
    Int J Cardiol; 2006 Aug; 111(3):386-93. PubMed ID: 16257073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HERG channel (dys)function revealed by dynamic action potential clamp technique.
    Berecki G; Zegers JG; Verkerk AO; Bhuiyan ZA; de Jonge B; Veldkamp MW; Wilders R; van Ginneken AC
    Biophys J; 2005 Jan; 88(1):566-78. PubMed ID: 15475579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Male and female equality: still far from goal.
    Grilo LS; Abriel H
    J Physiol; 2008 Jun; 586(12):2825-6. PubMed ID: 18556724
    [No Abstract]   [Full Text] [Related]  

  • 35. A minK-HERG complex regulates the cardiac potassium current I(Kr).
    McDonald TV; Yu Z; Ming Z; Palma E; Meyers MB; Wang KW; Goldstein SA; Fishman GI
    Nature; 1997 Jul; 388(6639):289-92. PubMed ID: 9230439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Saxitoxin is a gating modifier of HERG K+ channels.
    Wang J; Salata JJ; Bennett PB
    J Gen Physiol; 2003 Jun; 121(6):583-98. PubMed ID: 12771193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular genetic basis of sudden cardiac death.
    Towbin JA
    Pediatr Clin North Am; 2004 Oct; 51(5):1229-55. PubMed ID: 15331282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The IKr drug response is modulated by KCR1 in transfected cardiac and noncardiac cell lines.
    Kupershmidt S; Yang IC; Hayashi K; Wei J; Chanthaphaychith S; Petersen CI; Johns DC; George AL; Roden DM; Balser JR
    FASEB J; 2003 Dec; 17(15):2263-5. PubMed ID: 14525949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of irbesartan on cloned potassium channels involved in human cardiac repolarization.
    Moreno I; Caballero R; González T; Arias C; Valenzuela C; Iriepa I; Gálvez E; Tamargo J; Delpón E
    J Pharmacol Exp Ther; 2003 Feb; 304(2):862-73. PubMed ID: 12538844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Congenital and acquired long QT syndrome.
    Camm AJ; Janse MJ; Roden DM; Rosen MR; Cinca J; Cobbe SM
    Eur Heart J; 2000 Aug; 21(15):1232-7. PubMed ID: 10924312
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.